01 Expansion of Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis The balloon catheter market analysis shows that drug-coated balloons are gaining importance in the treatment of coronary in-stent restenosis. This encourages healthcare providers to use balloon catheters that deliver antiproliferative drugs directly to the vessel wall, helping limit tissue growth that can narrow previously treated arteries. For example, paclitaxel-coated coronary balloon systems are used in the treatment of in-stent restenosis, providing localized drug delivery without leaving an additional permanent implant.
02 Adoption of Intravascular Lithotripsy Balloons for Circumferential Calcium Modification Balloon catheter manufacturers are witnessing the adoption of intravascular lithotripsy systems for treating heavily calcified arterial lesions. This transition is encouraging clinicians to use balloon-based technologies that emit sonic pressure waves to modify calcium within the vessel wall before angioplasty or stent placement. Shockwave Medical’s intravascular lithotripsy balloon systems use sonic pressure waves to modify calcified plaque and facilitate vessel expansion during coronary and peripheral interventions.
01 Supply chain disruptions are expected to have a moderate impact on the balloon catheter market share due to dependence on medical-grade polymers, catheter shafts, inflatable balloon materials, specialized coatings, and precision manufacturing components. The market is likely to follow an S-shaped recovery, with gradual restoration of raw material supplies and manufacturing operations. Supply chain constraints could reduce market growth by 1.0–1.5 percentage points, lowering the projected CAGR of 11.20% to around 9.70%–10.20%. As supply conditions normalize, the balloon catheter market growth is expected to stabilize.
01 The balloon catheter market forecasts investment in advanced angioplasty devices, drug-coated balloon technologies, and minimally invasive vascular treatment solutions.
02 Key Investment and Funding Activities in Balloon Catheter Market, 2026 Company Value (USD) Details Advanced NanoTherapies USD 31 million In June 2026, Advanced NanoTherapies closed an oversubscribed Series B financing round exceeding USD 31 million to advance its drug-coated balloon technology for coronary and peripheral artery disease. Cagent Vascular USD 41 million In May 2026, Cagent Vascular raised USD 41 million in Series D funding to support the commercial expansion of its Serranator PTA Serration Balloon Catheter, which uses serration technology to treat peripheral artery disease.
01 Use of Balloon Catheters for Hemodialysis Fistula Angioplasty and Endoscopic Biliary Stricture Dilation Drives Market Need to maintain functional arteriovenous fistulas and grafts in patients undergoing hemodialysis is supporting demand for balloon catheters used in vascular access angioplasty. Stenosis in these access vessels restrict blood flow and interfere with effective dialysis, requiring balloon dilation to restore vessel patency. Thus, hospitals and vascular intervention centers use specialized balloon catheters to manage access dysfunction and reduce the need for surgical revision in suitable patients.Biliary strictures caused by conditions such as chronic pancreatitis, postoperative complications, and bile duct diseases are increasing the need for endoscopic balloon dilation procedures. These catheters help expand narrowed bile ducts during endoscopic retrograde cholangiopancreatography (ERCP), supporting bile flow and facilitating subsequent interventions when necessary. The use of balloon dilation in selected benign and malignant biliary strictures supports the demand for endoscopic balloon catheters with controlled inflation and precise positioning.
01 Difficulty in Dilating Heavily Calcified Lesions and Risk of Vessel Injury Restrain Adoption Heavily calcified arterial lesions create challenges for balloon catheter expansion because rigid plaque limits vessel compliance and may prevent adequate lumen enlargement during angioplasty. These cases often require additional lesion preparation techniques or specialized devices, increasing procedural complexity and treatment costs. Limited effectiveness in complex calcified vessels restrict the suitability of conventional balloon catheters for certain interventions.High-pressure balloon inflation during angioplasty causes vessel dissection, perforation, or other vascular injuries, particularly in fragile vessels or complex lesions. Such complications require additional interventions, prolonged procedural monitoring, or emergency treatment, increasing clinical risks for patients.
01 Development of Neurovascular Balloon Catheters and Advancements in Esophageal Dilation Technologies Offer Growth Opportunities Specialized neurovascular balloon catheters help dilate narrowed cerebral arteries in selected patients, supporting the restoration of blood flow when vasospasm requires endovascular intervention. Medical device manufacturers can benefit by developing low-profile, highly navigable balloon catheters that support precise placement within delicate cerebral vessels and improve procedural control.Specialized balloon dilation catheters help widen narrowed sections of the esophagus, improving the passage of food and relieving swallowing difficulties in appropriate patients. Medical device companies benefit by developing balloons with controlled expansion, graduated diameters, and improved pressure management to support more precise dilation and meet the needs of gastroenterology centers.